Authors:
SASAKI S
SUMINO K
HAMAJIMA K
FUKUSHIMA J
ISHII N
KAWAMOTO S
MOHRI H
KENSIL CR
OKUDA K
Citation: S. Sasaki et al., INDUCTION OF SYSTEMIC AND MUCOSAL IMMUNE-RESPONSES TO HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 BY A DNA VACCINE FORMULATED WITH QS-21 SAPONIN ADJUVANT VIA INTRAMUSCULAR AND INTRANASAL ROUTES, Journal of virology, 72(6), 1998, pp. 4931-4939
Authors:
CHAO AC
NGUYEN JV
BROUGHALL M
RECCHIA J
KENSIL CR
DADDONA PE
FIX JA
Citation: Ac. Chao et al., ENHANCEMENT OF INTESTINAL MODEL-COMPOUND TRANSPORT BY DS-1, A MODIFIED QUILLAJA SAPONIN, Journal of pharmaceutical sciences, 87(11), 1998, pp. 1395-1399
Citation: Dj. Pillion et al., STRUCTURE-FUNCTION RELATIONSHIP AMONG QUILLAJA SAPONINS SERVING AS EXCIPIENTS FOR NASAL AND OCULAR DELIVERY OF INSULIN, Journal of pharmaceutical sciences, 85(5), 1996, pp. 518-524
Authors:
CLELAND JL
KENSIL CR
LIM A
JACOBSEN NE
BASA L
SPELLMAN M
WHEELER DA
WU JY
POWELL MF
Citation: Jl. Cleland et al., ISOMERIZATION AND FORMULATION STABILITY OF THE VACCINE ADJUVANT QS-21, Journal of pharmaceutical sciences, 85(1), 1996, pp. 22-28
Authors:
JACOBSEN NE
FAIRBROTHER WJ
KENSIL CR
LIM A
WHEELER DA
POWELL MF
Citation: Ne. Jacobsen et al., STRUCTURE OF THE SAPONIN ADJUVANT QS-21 AND ITS BASE-CATALYZED ISOMERIZATION PRODUCT BY H-1 AND NATURAL-ABUNDANCE C-13 NMR-SPECTROSCOPY, Carbohydrate research, 280(1), 1996, pp. 1-14
Authors:
POWELL MF
EASTMAN DJ
LIM A
LUCAS C
PETERSON M
VENNARI J
WEISSBURG RP
WRIN T
KENSIL CR
NEWMAN MJ
NUNBERG J
CLELAND JL
GREGORY TJ
BERMAN PW
Citation: Mf. Powell et al., EFFECT OF ADJUVANTS ON IMMUNOGENICITY OF MN RECOMBINANT GLYCOPROTEIN-120 IN GUINEA-PIGS, AIDS research and human retroviruses, 11(2), 1995, pp. 203-209
Citation: J. Recchia et al., A SEMISYNTHETIC QUILLAJA SAPONIN AS A DRUG-DELIVERY AGENT FOR AMINOGLYCOSIDE ANTIBIOTICS, Pharmaceutical research, 12(12), 1995, pp. 1917-1923
Authors:
SOLTYSIK S
WU JY
RECCHIA J
WHEELER DA
NEWMAN MJ
COUGHLIN RT
KENSIL CR
Citation: S. Soltysik et al., STRUCTURE-FUNCTION STUDIES OF QS-21 ADJUVANT - ASSESSMENT OF TRITERPENE ALDEHYDE AND GLUCURONIC-ACID ROLES IN ADJUVANT FUNCTION, Vaccine, 13(15), 1995, pp. 1403-1410
Authors:
PILLION DJ
RECCHIA J
WANG P
MARCIANI DJ
KENSIL CR
Citation: Dj. Pillion et al., DS-1, A MODIFIED QUILLAJA SAPONIN, ENHANCES OCULAR AND NASAL ABSORPTION OF INSULIN, Journal of pharmaceutical sciences, 84(11), 1995, pp. 1276-1279
Authors:
NEWMAN MJ
MUNROE KJ
ANDERSON CA
MURPHY CI
PANICALI DL
SEALS JR
WU JY
WYAND MS
KENSIL CR
Citation: Mj. Newman et al., INDUCTION OF ANTIGEN-SPECIFIC KILLER T-LYMPHOCYTE RESPONSES USING SUBUNIT SIVMAC251 GAG AND ENV VACCINES CONTAINING QS-21 SAPONIN ADJUVANT, AIDS research and human retroviruses, 10(7), 1994, pp. 853-861
Citation: Mj. Newman et al., ACCESSORY CELL REQUIREMENTS FOR SAPONIN ADJUVANT (QS-21) AUGMENTATIONOF B-LYMPHOCYTE AND T-LYMPHOCYTE RESPONSES, AIDS research and human retroviruses, 10, 1994, pp. 190000116-190000116
Authors:
LIVINGSTON PO
ADLURI S
HELLING F
YAO TJ
KENSIL CR
NEWMAN MJ
MARCIANI D
Citation: Po. Livingston et al., PHASE-1 TRIAL OF IMMUNOLOGICAL ADJUVANT QS-21 WITH A GM2 GANGLIOSIDE-KEYHOLE LIMPET HEMOCYANIN CONJUGATE VACCINE IN PATIENTS WITH MALIGNANT-MELANOMA, Vaccine, 12(14), 1994, pp. 1275-1280
Authors:
MA JN
BULGER PA
DAVIS DV
PERILLIPALMER B
BEDORE DA
KENSIL CR
YOUNG EM
HUNG CH
SEALS JR
PAVIA CS
COUGHLIN RT
Citation: Jn. Ma et al., IMPACT OF THE SAPONIN ADJUVANT QS-21 AND ALUMINUM HYDROXIDE ON THE IMMUNOGENICITY OF RECOMBINANT OSPA AND OSPB OF BORRELIA-BURGDORFERI, Vaccine, 12(10), 1994, pp. 925-932
Citation: Mj. Newman et al., SAPONIN (QS-21) ADJUVANT ACTIVITY IN NONHUMAN-PRIMATES, AIDS research and human retroviruses, 9, 1993, pp. 190000094-190000094